muraglitazar has been researched along with ursodeoxycholic acid in 1 studies
| Studies (muraglitazar) | Trials (muraglitazar) | Recent Studies (post-2010) (muraglitazar) | Studies (ursodeoxycholic acid) | Trials (ursodeoxycholic acid) | Recent Studies (post-2010) (ursodeoxycholic acid) |
|---|---|---|---|---|---|
| 85 | 10 | 25 | 4,592 | 626 | 1,561 |
| Protein | Taxonomy | muraglitazar (IC50) | ursodeoxycholic acid (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Sodium/bile acid cotransporter | Homo sapiens (human) | 3.6 | |
| M1-family alanyl aminopeptidase | Plasmodium falciparum 3D7 | 2.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moseley, RH | 1 |
1 other study(ies) available for muraglitazar and ursodeoxycholic acid
| Article | Year |
|---|---|
Therapy for nonalcoholic fatty liver disease.
Topics: Animals; Antioxidants; Cholagogues and Choleretics; Disease Models, Animal; Fatty Liver; Glycine; Humans; Hypolipidemic Agents; Insulin Resistance; Liver; Mice; Oxazoles; Peroxisome Proliferator-Activated Receptors; Rats; Thiazolidinediones; Treatment Outcome; Ursodeoxycholic Acid; Vitamin E | 2008 |